SUMMARY, Epithelial ion channels and transporter proteins have physiologically important roles throughout the length of the nephron. Discovering the molecular identities of tubular epithelial cell proteins and their functional roles has increased understanding of both renal physiology and tubular diseases. Defects in tubular handling of solutes may present with nephrocalcinosis or nephrolithiasis, rickets, acid-base, electrolyte or blood pressure disturbances. Biochemical analysis of both serum and urine. together with clinical history and examination. remain fundamental for their diagnosis, whilst understanding of underlying molecular mechanisms allows appropriate management.
The renal tubule is responsible for the regulation and control of the solute content of the body by reabsorption and secretion of water and ions. It does this by means of epithelial ion channels and transporters, which have specific locations and functions ( Fig. I) and are highly regulated. Recent advances in molecular medicine havẽ lIowed new insights into the precise mechanI~ms underlying tubular disorders and have shed hght on both renal tubular physiology and the pharmacology of diuretics (Table I ). In this review we give a brief overview of renal tubular P?ysiology with respect to electrolyte handling, dIscuss general reasons to suspect an inherited t~bulopathy in a patient, discuss the differential dIagnosis of hypokalaemia and review individual conditions with respect to clinical features and diagnosis. We have omitted discussion of nephrogenic diabetes insipidus, renal tubular acidoses and disorders of calcium-sensing because these have been recently reviewed in this journal, or elsewhere.' 3 
OVERVIEW OF PHYSIOLOGY
Formation of urine relies on glomerular filtration, tubular reabsorption and tubular secretion. Glomerular filtration produces> 160L of filtrate This article was prepared at the invitation of the Clinical LahoTlltory lnvestigution Standing Committee of the Associalion of Clinical Biochemists, Correspondence: Dr John Sayer. E-mail: j.a.sayeruoncl.ac.uk per day in a normal adult, and 99% of this volume and the majority of accompanying filtered solutes are required to be reabsorbed by the renal tubule and returned to the circulation. The proximal tubule (PT) is responsible for reabsorption of glucose, phosphate, amino acids. low-molecular-weight proteins and 60% of filtered sodium. Sodium is reabsorbed in an energy-dependent manner, driven by a basolateral (parenchymal surface) Na +-K +-ATPase. A variety of apical (luminal surface) sodium cotransporters allow for reabsorption of both organic (glucose/amino acids) and inorganic (CI-, phosphate) solutes. Removal of solutes from the lumen in this way lowers the tubular fluid osmolality, creates an osmotic gradient and permits passive water reabsorption through the highly permeable PT. Apical sodium hydrogen exchangers allow sodium ions to be reabsorbed in exchange for H'; this permits bicarbonate reabsorption via carbonic anhydrases that are present both in the brush border and intracellularly.
In the thick ascending limb (TAL) of the loop of Henle, 30% of the filtered sodium is reabsorbed. Here transcellular transport of sodium is achieved by a Na ' --K '-2C1--cotrunsporter (NKCC2) in the apical membrane, driven by a favourable inward gradient of sodium generated by the basolateral Nat-K' -ATPase pump. Potassium entering the cell from the lumen is recycled back via a potassium-secreting channel (ROMK1) in the apical membrane. This movement of potassium is electrogenic and drives paracellular reabsorption of sodium, calcium and magnesium, which is regulated by paracellular tight-junction proteins (including paracellin-l). Chloride leaves the cell basolaterally via chloride channels, including CLC-Kb (Fig. 2) . Osmotically driven water reabsorption continues in the descending limb but the TAL is water-impermeable. The distal convoluted tubule (OCT) reabsorbs 5-8% of the filtered sodium via the Na +-CIcotransporter (NCCT). Calcium absorption occurs throughout the tubule (PT 70%, TAL 20%, OCT 7%, collecting duct 2%) but is specifically regulated in the OCT. Here calcium reabsorption is primarily under control of parathyroid hormone and the calcium-sensing receptor. Entry of calcium from the lumen occurs via an apical epithelial calcium channel; it then binds to calbindin and diffuses through the cell to the basolateral membranes, where calcium ions are extruded by a Ca 2 +-ATPase and Na +-Ca2+ exchanger.
Principal cells in the cortical collecting duct and inner medullary collecting duct play the final role in sodium and water absorption and in potassium excretion. Sodium entry in collecting tubules occurs via selective sodium channels (ENaCs) in the apical membrane. promoting secretion of potassium. The distribution of ENaC channels to the apical plasma membrane is regulated by the effects of aldosterone on the mineralocorticoid receptor (MR). This receptor may also be stimulated by cortisol, but this effect is diminished by the enzyme Illl-hydroxysteroid dehydrogenase, which inactivates cortisolto cortisone (Fig. 3) . Water reabsorption is ;;.
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.... r immature tubular physiology and the low-salt Intakes in standard feeds. As the nephron matures, the propensity to present with 'saltlosing crisis' diminishes.
Individual tubular diseases can be differentiated by their distinct biochemical profiles together with a range of additional clinical features and, on occasion, by elucidation of the precise molecular defect. In many cases a careful evaluation of the urine biochemistry holds the key to the correct diagnosis, and this is as important in the work-up of these conditions as the serum biochemistry.
Hypokalaemia may be the only diagnostic clue on initial investigations and it is important to follow this diagnostic 'lead' to differentiate the many causes (see Fig. 4 ). Hypokalaemic disorders may be distinguished by various factors, including the presence of alkalosis, elevation of blood pressure and measurement of the source of electrolyte loss (urinary or gastrointestinal tract) by urinary chloride and potassium estimation. These basic investigations allow the differential diagnosis to be narrowed, and a final diagnosis is then made by more specific testing.
In a similar manner, evidence of nephrocalcinosis or renal stones cannot be ignored. The differential diagnosis of nephrocalcinosis is broad. Systemic diseases such as hyperparathyroidism, vitamin D intoxication and sarcoidosis should first be excluded. The remainder may be associated with tubular disorders. Distal renal tubular acidosis, idiopathic hypercalciuria, hypomagnesaemic hypercalciuric nephrolithiasis, Bartter's syndrome and Dent's disease are all associated with nephrocalcinosis and are best investigated by urine pH and 24-h urine for calcium, magnesium. citrate and phosphate, combined with serum electrolyte measurements.
The presence of low-molecular-weight proteinuria (LMWP) is also important and has been used to screen patients for Fanconi syndromes.
These low-molecular-weight proteins include IX.-microglobulin (molecular weight 30000) and retinol-binding protein (RBP) (molecular weight 21000). Although fJ2-microglobulin is commonly assayed, it is unstable and assay of other lowmolecular-weight proteins is recommended. It must be remembered that these proteins are not detected by standard urine dipsticks (which detect albuminuria). Loss of low-molecularweight protein from a proximal tubular origin (i.e. tubular proteinuria) may be distinguished from glomerular loss of protein by measuring urinary levels of both RBP and albumin. Norden et al. have shown" that the ratio of urinary RBP to urinary albumin identifies all patients with an inherited Fanconi syndrome (including Dent's disease) and clearly distinguishes their LMWP from that of distal renal tubular acidosis and glomerulonephritis. In addition, in the absence of infection or obstruction, LMWP in a renal stone former is highly suggestive of Dent's disease' and further investigation is indicated.
However, inherited tubular disorders are rare and the typical biochemical picture of some can be induced by diuretic use (prescribed or otherwise), laxative abuse and chronic liquorice ingestion. Careful drug and dietary histories, together with urine electrolyte and diuretic screening, are often required in the investigation of these disorders.
INHERITED FANCONJ SYNDROMES
The Fanconi syndrome refers to the clinical picture seen when there is generalized impairment in PT function. The consequences are hypophosphataemia (which can lead to rickets/ osteomalacia), renal glucosuria, hypouricaemia, aminoaciduria, LMWP and type 2 (proximal) renal tubular acidosis due to bicarbonate loss in the urine. Inherited Fanconi syndromes may be primary (e.g. Lowe's syndrome and autosomal dominant adult Fanconi syndrome") or associated with other metabolic disease (e.g. Wilson's disease). Dent's disease gives a renal Fanconi syndrome with the additional findings of hypercalciuria and renal stone formation. The differential diagnosis of inherited Fanconi syndromes includes non-genetic tubulopathies. Heavy metals (e.g. mercury, lead, cadmium) and many drugs, including gentamicin, cisplatin and ifosfamide, may all cause a renal Fanconi syndrome secondary to PT toxicity,
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Lowe's syndrome (oculocerebrorenal dystrophy) This X-linked syndrome has features that include congenital cataracts and mental retardation together with progressive renal failure in affected males. The renal abnormalities are those of Fanconi syndrome and include proteinuria (which develops from early infancy), aminoaciduria, mild glycosuria, phosphaturia and renal tubular acidosis." In female carriers, the only sign may be micro punctate cortical lens opacities. The faulty gene has been identified as OCRL-1 8 and the deficient protein as phosphatidylinositol-4,5-bisphosphate 5-phosphatase,9 which allows prenatal diagnosis to be made on biochemical grounds,'? but unfortunately no specific treatments are available. The precise molecular mechanisms remain unclear, but there is evidence that OCRL plays a specific role in the regulation and trafficking of lysosomal enzymes in proximal tubular cells, with loss of function leading to tissue damage.U{'
Wilson's disease Wilson's disease is an autosomal recessive copper-handling disorder, with an approximate incidence of I in 30000. It is caused by mutations in the A TP7B gene," which encodes for a coppertransporting ATPase, expressed in both liver and kidney. The disease is characterized by excessive accumulation ofcopper in liver, basal ganglia and renal tubules. This copper deposition causes neurological symptoms, corneal rings (KayserFleischer rings in Descemet's membranes), liver cirrhosis and renal tubular dysfunction." Biochemical abnormalities include aminoaciduria, hypercalciuria, hypophosphataemia, nephrocalcinosis and renal stones. These renal manifestations are important to note as, although rare, they can start at any age and may be a presenting sign of Wilson's disease." The diagnosis is made by low total serum copper and caeruloplasmin concentrations and increased urinary copper. Neonatal diagnosis may be made by measurement of caeruloplasmin using cord blood/blood spots." Treatment is with copper-chelating agents.
Dent's disease This X-linked condition is characterized by LMWP, hypercalciuria, aminoaciduria, hypophosphataemia and rickets.'? In affected men, progressive nephrocalcinosis. renal calculi and end-stage renal failure are seen by late adolescence or early adulthood. Carrier women have urinary abnormalities, but rarely develop complications. Mutations in a renal chloride channel, CLC-5, underlie this condition. 18 CLC-5 expression is seen at multiple nephron segments as suggested by the broad phenotype of Dent's disease. 19 CLC-5 function seems to be important for endosomal acidification and protein trafficking, but its precise physiological role has yet to be determined.v-" Dent's disease is distinguished from other causes of proximal tubular disease by the more marked disease displayed in men together with the development of severe nephrocalcinosis and renal stones. Typically, affected men have urinary levels of P2-microglobulin 100-300 times the upper limit of normal, and urinary RBP 1000-3000 times the upper limit of normal." LMWP may also be used as a screening test for carriers," and the combined measurement of urinary albumin and RBP can be used to confirm the tubular origin of the proteinuria."
Treatment consists of managing infected and obstructive renal stones. Hypercalciuria may be reduced by treatment with thiazide diuretics, amiloride and a low-sodium, low-protein diet. Rickets is treated with vitamin D with careful monitoring of urinary calcium." Renal transplantation is curative and there is no recurrence of nephrocalcinosis.
INHERITED DISORDERS OF THE LOOP OF HENLE AND DISTAL TUBULE
Bartter's syndrome This recessive disorder is characterized by renal salt wasting and a hypokalaemic metabolic alkalosis (with normocalciuria or hypercalciuria) due to mutations in the membrane transporters of the epithelial cells of the meduIlary TAL. The incidence is estimated to be 1·2 per million.P The biochemical findings mimic those of prolonged or high-dose exposure to a loop diuretic. Polyuria and polydipsia are invariably present in children and adults presenting with Bartter's syndrome. However, the majority present as neonates, either with salt-losing crises or presenting after maternal polyhydramnios (probably due to excessive urine production in utero) or premature labour." The blood pressure is typicaIly at the lower end of the normal range, and salt wasting gives rise to profound activation of the renin-angiotensin Il-aldosterone axis, associated with hyperplasia of the juxtaglomerular apparatus, as originally described by Bartter et al. 24 In addition, the activation of the renin-angiotensin-aldosterone axis results in increased sodium reabsorption in the distal nephron in exchange for K + and H + , leading to a hypokalaemic alkalosis. Furthermore, there are variable somatic features including failure to thrive in infancy, short stature and learning difficulties.
Mutations in the genes encoding the NKCC2, ROMKl and CLC-Kb transporters or channels have each been described in different kindreds 25 -27 with hypokalaemic metabolic alkalosis and renal salt wasting being common features, and mild hypomagnesaemia being found in one-third."
The identification of the primary genetic defects has improved our understanding of the highly variable phenotype. Thus, polyhydramnios, premature birth, life-threatening saltwasting in the perinatal period, hypercalciuria and impaired urinary concentration (antenatal Bartter's syndrome) are usuaIly due to mutations in ROMKI or NKCC2, whereas a presentation of weakness and hypovolaemia during the first years of life, only mild impairment of urinary concentrating ability and normal urinary calcium (classic Bartter's syndrome) are commonly due to mutations in CLC-Kb. Patients with ROMKI defects have less severe hypokalaemia," and nephrocalcinosis or renal stone formation is rarely found in Bartter's syndrome due to CLC-Kb mutations." However, the fuIl clinical characterization of CLC-Kb mutations reveals a variable and unpredictable phenotype, which ranges from a neonatal life-threatening presentation through to asymptomatic patients presenting in adulthood." In addition, a number of patients with CLC-Kb mutations have a Gitelman's-like phenotype with low urinary calcium and profound hypomagnesaemia."-" possibly implicating an interaction between CLC-Kb and NCCT in the DCT. Thus, there are subtle differences in tubular handling of electrolytes between subjects with different molecular variants.
A prenatal diagnosis of Bartter's syndrome may be made when a pregnancy is complicated by severe polyhydramnios (reported as early as 20 weeksj." Amniotic fluid biochemistry after amniocentesis shows raised chloride and aldosterone levels,33.34 and a corresponding depletion of electrolytes (low chloride, sodium and calcium) has been observed in maternal urine." Prenatal diagnosis is important, as early neonatal treatment may be life-saving and prenatal treatment of maternal polyhydramnios with indomethacin may be beneficial." Genetic testing is arduous (three large genes have to be analysed) but may allow precise molecular diagnosis and add some prognostic information; unfortunately this is not routinely available in the UK.
The clinical diagnosis is usually made by excluding other causes of hypokalaemic metabolic alkalosis in a normotensive patient (e.g. surreptitious vomiting and diuretic abuse). Renin and aldosterone levels are high (due to secondary activation) but are not specific to Bartter's syndrome. Urinary chloride levels are raised in a euvolaemic patient (> 20 mrnol/L), which excludes gastrointestinal chloride loss and together with a negative urine assay for diuretics suggests an inherited tubulopathy. The presence of hypercalciuria or urinary calcium excretion towards the upper limit of normal (urine calcium:creatinine molar ratio >0·2) and a serum magnesium above 0·65 mmol/L usually differentiates Bartter's syndrome from Gitelman's syndrome.P Treatment includes potassium supplementation, often combined with potassium-sparing diuretics (such as spironolactone or amiloride in higher than usual doses of up to 300 and 40 mg/day, respectively). A similar rise in serum potassium may be achieved with angiotensinconverting enzyme inhibitors," although symptomatic hypotension may be a problem with this therapy. Non-steroidal anti-inflammatory drugs, including specific cycle-oxygenase (COX-2) inhibitors, suppress prostaglandin-stimulated renin release and have been shown to be effective in improving both electrolyte imbalance and skeletal growth in Bartter's patients. 38 • 39
Gltelman's syndrome This recessive disorder is characterized by hypokalaemic hypomagnesaemic alkalosis/" but unlike Bartter's syndrome it is often asymptomatic into adult life. Patients may present with weakness, paraesthesia, tetany and severe fatigue. The molecular basis for the disorder is mutation in the gene encoding the thiazidesensitive NCCT transporter in the DCT. 41 Thus, the serum and urine electrolyte disorders mimic those of chronic thiazide diuretic exposure, with blood pressure often lower than average. The distinction from Bartter's syndrome is often straightforward on clinical grounds, including a lack of somatic features, more severe hypornagnesaemia and hypocalciuria, in contrast to the normo-or hypercalciuria found in Bartter's syndrome. A urinary calcium:creatinine molar ratio < O·2 together with a low plasma magnesium «0·65 mmol/L) are diagnostic for Gitelman's, Ann Clin Biochem 2001: 38 once thiazide use is excluded." The exact mechanisms underlying the hypocalciuria and urinary magnesium wasting are not known, but are likely to be secondary to the primary defect in the NCCT. Defective NCCT, resulting in a reduction in intracellular sodium, may stimulate both a basolateral Na +-ea 2 + exchanger, leading to low intracellular calcium and increased uptake from the lumen.f and a postulated apical Na +_Mg2+ exchanger, leading to sodium entry and magnesium wasting.f!
Hypomagnesaemic hypercalciuric nephrocalcinosis
This rare autosomal recessive condition is characterized by early-onset nephrocalcinosis and nephrolithiasis, associated with profound hypomagnesaemia and hypercalciuria." This condition was previously reported as the congenital 'magnesium-losing kidney' . 46 Progressive renal failure is the norm, leading to renal failure in late childhood or adolescence. Mutations in the gene encoding a paracellular tight-junction protein, paracellin-l, are responsible.v leading to impaired paracellular magnesium reabsorption in the TAL and some more-distal nephron segments. The diagnosis is made by finding hypomagnesaemia with inappropriately high urinary magnesium excretion. Use of a combination of magnesium salts, potassium citrate and thiazide diuretics aims to reduce progressive nephrocalcinosis, but only renal transplant is curative."
Liddle's syndrome
This autosomal dominant condition is typified by hypertension, hypokalaemic metabolic alkalosis and suppressed renin and aldosterone levels." A strong family history of premature stroke may be found. However, the manifestations may be variably penetrant and appear to be dependent on environmental factors such as sodium intake. Thus, some affected family members can be either normokalaemic or normotensive." Mutations that increase sodium reabsorption through the collecting duct epithelial sodium channel, ENaC, cause Liddle's syndrome. The 'open' ENaC channels allow unregulated sodium reabsorption, thus causing hypertension. The ENaC is heterotrimeric and mutations at a limited number of positions in the p-and )I-subunits can cause the constitutive opening necessary for the Liddle's phenotype.v" Liddle's syndrome should be suspected in a young person presenting with hypertension, low serum potassium and metabolic alkalosis. Serum and urine aldosterone levels are low and the differential diagnosis includes some forms of congenital adrenal hyperplasia, the syndrome of apparent mineralocorticoid excess, carbenoxolone therapy and chronic liquorice ingestion. Activating mutations of ENaC genes are rare but polyrnorphisms with more subtle effects may be common, especially in black populations." Up to 5% of 'essential' hypertension may therefore be due to Liddle's syndrome.P-" Treatment in Liddle's syndrome consists of sodium restriction," together with the potassiumsparing diuretics amiloride or triamterene, which directly inhibit the ENaC. The mineralocorticoid antagonist spironolactone is ineffective, since the increase in sodium channel activity is not mediated by aldosterone.
Pseudohypoaldosteronism type I This rare disorder of infancy may manifest with failure to thrive due to salt wasting associated with hypotension, hyperkalaemia and massive elevations in renin and atdosterone.P-" It may be found as both an autosomal dominant and an autosomal recessive trait. 58.59 Two different molecular mechanisms are responsible, with autosomal recessive cases (type Ia) being due to inactivating defects of any of the three ENaC subunits making them inactive and unresponsive to the effects of aldosterone/"
In addition. in type Ia, ENaC function in lung epithelia may be impaired, leading to cough and recurrent respiratory tract infections.s' Autosomal dominant cases of pseudo hypo aidosteronism type Ib have been shown to be due to mutations in the mineralocorticoid receptor (MR) gene." This disease has clinical features of aldosterone resistance but is typically milder and may remit with increasing age.
Volume depletion is treated by a high-sodium diet. which also enhances potassium secretion in the collecting duct. Addition of high-dose fludrocortisone or carbenoxolone may be required, although fludrocortisone may be less effective if a mutation affecting MR function is present.v' Gordon's syndrome (pseudohypoaldosteronism type II) This dominantly inherited condition is characterized by hyperkalaemia, hypertension and mild hyperchloraemic metabolic acidosis. 64, 65 The presentation may be with hyperkalaemic acidosis in the neonatal period or with hypertension in adolescents and young adults. The primary defect seems to be enhanced distal chloride reabsorption in preference to excretion of potassium.t" Initially. because thiazide diuretics are an effective treatment, an activating mutation of NCCT was thought to be implicated. However, genetic mapping studies have located three different chromosomal loci in families with Gordon's syndrome,65,66 none of which correspond to NCCT. The precise genetic defects have yet to be identified. The diagnosis is made by exclusion. Therapy includes a lowpotassium diet and a thiazide diuretic. Salt (sodium) loading should be avoided as it worsens the hypertension.
CONCLUSION
Advances in the molecular genetics of inherited renal tubulopathies have allowed insight into the normal mechanisms of tubular cation and anion reabsorption. Intricate and diverse molecular mechanisms have been shown to take place in each nephron segment. Normal PT function relies on the correct localization and regulation of multiple channels and transporters, with single gene defects and toxicity resulting in generalized impairment. More distally, it is now possible to view Bartter's syndrome, Gitelman's syndrome and pseudohypoaldosteronism type I as having genetic abnormalities which produce tubular defects that are similar to those induced by the pharmacological actions of loop diuretics, thiazide diuretics or potassium-sparing diuretics, respectively. Although these rare monogenic disorders with dramatic phenotypes seem to have little relevance to everyday clinical practice, it is likely that more subtle abnormalities of the regulation of ENaC may play a role in lowrenin forms of 'essential' hypertension. Similarly, subtle abnormalities in the function of NKCC2, NCCT. paracellin channels and CLC-type chloride channels may be major determinants of urinary calcium excretion, with possible roles in the pathogenesis of hypercalciuria and osteoporosis, It is likely that other renal channels and transporters will be implicated in the pathogenesis of further monogenic disorders, allowing our understanding of tubular functioning to be further increased.
